Overview

Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus

Status:
Completed

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

Summary

To demonstrate the ability of Aurstat to reduce pruritus in subjects with mild to moderate atopic dermatitis. Efficacy results will be based on subject assessment, IGA, and photographic evidence based on ordinal scales for tolerability.

Phase:

Phase 2

Details

Lead Sponsor:

The Center for Clinical and Cosmetic Research

Collaborator:

Onset Dermatologics, Inc.

Treatments:

Diphenhydramine
Promethazine